SEC Form 4 · accession 0001652252-18-000033
BIO-RAD LABORATORIES, INC. · BIO BIO.B
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Christine A Tsingos
Officer — EVP and CFO
Period of report
Sep 5, 2018
Accepted (ET)
Sep 6, 2018 · 8:12 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000012208
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Bio-Rad A Common StockF1 | Sep 5, 2018 | M | 600 | $0.00 | A | 7,283 | D | |
| Bio-Rad A Common Stock | Sep 5, 2018 | F | 208 | $315.50 | D | 7,075 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitsF2,F3 | $0.00 | Sep 5, 2018 | M | 600 | D | — | — | Bio-Rad A Common Stock | 600 | 2,400 | D |
Explanation of responses
- F1Shares of Class A common stock acquired on the vesting of restricted stock units.
- F2Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock.
- F3The restricted stock units vest in five equal annual installments beginning September 5, 2018.